• 검색 결과가 없습니다.

Acupuncture for Chronic Fatigue Syndrome and Idiopathic Chronic Fatigue : a Protocol for a Pilot Randomized Controlled Trial

N/A
N/A
Protected

Academic year: 2021

Share "Acupuncture for Chronic Fatigue Syndrome and Idiopathic Chronic Fatigue : a Protocol for a Pilot Randomized Controlled Trial"

Copied!
13
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)

경락경혈학회지 Vol.28, No.3, pp.151 163, 2011∼ Korean Journal of Acupuncture

- 151 -

Jung-Eun Kim , Kyung-Won Kang , Tae-Hun Kim , So-Yong Jung , Ae-Ran Kim Mi-Suk Shin , Hyo-Ju Park , Kwon-Eui Hong , Sun-Mi Choi

Acupuncture, Moxibustion & Meridian Research Center, Korea Institute of Oriental Medicine Dept. of Acupuncture & Moxibustion, College of Oriental Medicine, Dae-Jeon University

Abstract

Objectives : Our aim is to evaluate feasibility for massive clinical research and to make basic analysis of efficacy and safety of acupuncture treatment for chronic fatigue syndrome and idiopathic chronic fatigue.

Methods : This study is a protocol for a pilot randomized controlled trial. It was developed through literature searches and discussions among researchers.

Results : Forty participants allocated to acupuncture group and wait-list group. Participants allocated to acupuncture group will be treated three times per week for a total of 12 sessions over four weeks. Eight points (GV20; bilatral GB20, BL11, BL13, BL15, BL18, BL20, BL23) have been selected for the acupuncture group. Participants in the wait-list group will not receive acupuncture treatment during study period and follow-up will be made in the 5th and 9th weeks after random allocation. Then the same acupuncture treatment as that performed to the acupuncture group will be made to the wait-list group. Fatigue Severity Scale, a short form of Stress Response Inventory, Beck Depression Inventory, and Insomnia Severity Index will be used as outcome variables to evaluate the efficacy of acupuncture. Safety will be assessed at every visit.

Conclusions : The trial based on this study will be performed. The results of the trial will provide basis for the efficacy and safety of acupuncture treatment for chronic fatigue syndrome and idiopathic chronic fatigue.

Key words : Acupuncture, Chronic fatigue, Pilot trial

(2)
(3)

- 153 - Table 1. Eligibility criteria

(4)

Table 2. Schedule for treatment and outcome measurement

(5)

- 155 -

(6)

Table 3. Revised STRICTA (Standards for Reporting Interventions in Clinical Trials of Acupuncture)

(7)

- 157 -

(8)
(9)

- 159 -

(10)
(11)

- 161 -

(12)
(13)

- 163 -

수치

Table 2. Schedule for treatment and outcome measurement
Table 3. Revised STRICTA (Standards for Reporting Interventions in Clinical Trials of Acupuncture)

참조

관련 문서

Conclusions The results of this study will be used to determine the feasibility of a fu- ture large-scale randomized controlled trial that provides clinical evidence for the

Effects of a Laughter Therapy on Depression, Anxiety, Fatigue and Quality of Sleep in Gastrointestinal Cancer Patients Post-Treatment: a Randomized Controlled Trial.. Park, SeYeon 1

In summary, the SNUG study is a multicenter, ran- domized, double-blind, placebo-controlled clinical trial that will evaluate the efficacy and safety of PG102P ver- sus placebo

시험군은 평균 21.. Na-Eun Choi, et al. Randomized, Placebo-Controlled, Double-Blind, Multi-Center, Clinical Study to Evaluate the Efficacy of ZEREX in Female Young Adult with

Current management of KDOA takes a comprehensive approach including pharmacological and non-pharmacological interventions. Recently, there have been increased interests

Objectives : We investigated the efficacy and safety of miniscalpel acupuncture (MA) treatment combined with non-steroidal anti-inflammatory drugs (NSAIDs) for chronic neck pain

Conclusions : This clinical trial, as the pilot study for a future large-scale trial, will provide clinical information for evaluating the efficacy and safety of GMD and

Recently, there has been increased interest in the use of acupuncture for treating disease 20) , and acupuncture is widely used to treat cancer-related pain 21). At